Hammada scoparia flavonoids and rutin kill adherent and chemoresistant leukemic cells
- 1 August 2011
- journal article
- Published by Elsevier BV in Leukemia Research
- Vol. 35 (8), 1093-1101
- https://doi.org/10.1016/j.leukres.2010.12.011
Abstract
No abstract availableKeywords
Funding Information
- Association de recherche contre le cancer
- Institut National Du Cancer
This publication has 28 references indexed in Scilit:
- Clinical activity of sequential flavopiridol, cytosine arabinoside, and mitoxantrone for adults with newly diagnosed, poor-risk acute myelogenous leukemiaLeukemia Research, 2010
- Phase I clinical and pharmacokinetic study of a novel schedule of flavopiridol in relapsed or refractory acute leukemiasHaematologica, 2010
- Induction of cell cycle entry eliminates human leukemia stem cells in a mouse model of AMLNature Biotechnology, 2010
- Targeting the leukemic stem cell: the Holy Grail of leukemia therapyLeukemia, 2008
- Glycogen Synthase Kinase-3 Inhibition Induces Glioma Cell Death through c-MYC, Nuclear Factor-κB, and Glucose RegulationCancer Research, 2008
- Sequential Flavopiridol, Cytosine Arabinoside, and Mitoxantrone: A Phase II Trial in Adults with Poor-Risk Acute Myelogenous LeukemiaClinical Cancer Research, 2007
- Flavopiridol administered using a pharmacologically derived schedule is associated with marked clinical efficacy in refractory, genetically high-risk chronic lymphocytic leukemiaBlood, 2006
- mTOR regulates cell survival after etoposide treatment in primary AML cellsBlood, 2005
- Glycogen Synthase Kinase 3 Phosphorylates RBL2/p130 during QuiescenceMolecular and Cellular Biology, 2004
- Forkhead transcription factor FOXO3a protects quiescent cells from oxidative stressNature, 2002